首页> 外国专利> METHOD OF SPECTROMETRIC DETERMINATION OF CONCENTRATION OF 146S FOOT-AND-MOUTH DISEASE VIRUS PARTICLES IN NON-INACTIVATED RAW MATERIAL FOR A VACCINE BY ESTIMATING THE NUMBER OF MOLECULES OF VIRAL RNA RELEASED AFTER IMMUNE CAPTURE OF VIRIONS

METHOD OF SPECTROMETRIC DETERMINATION OF CONCENTRATION OF 146S FOOT-AND-MOUTH DISEASE VIRUS PARTICLES IN NON-INACTIVATED RAW MATERIAL FOR A VACCINE BY ESTIMATING THE NUMBER OF MOLECULES OF VIRAL RNA RELEASED AFTER IMMUNE CAPTURE OF VIRIONS

机译:通过估计病毒免疫捕获后释放的病毒RNA分子数量的光谱法测定非灭活疫苗原料中146S足和口病病毒颗粒的浓度

摘要

FIELD: biotechnology.;SUBSTANCE: invention relates to biotechnology and specifically to production of the fauna vaccines, and can be used to determine concentration of 146S foot-and-mouth disease virus particles in non-inactivated raw materials for vaccine production. That is ensured by evaluating the number of viral RNA molecules recovered after virion immune capture. RNA is isolated from immune complexes "146S particle-antibody". Degree of purity of RNA extracts is assessed by spectral analysis and gel electrophoresis. Series of dilutions of a positive standard of foot-and-mouth disease RNA virus with a number of molecules corresponding to concentrations of 146S particles from 0.1 to 4.0 mcg/ml with a dilution interval of 0.1 mcg/ml is prepared. Number of RNA molecules is calculated from the absorption spectrum. Dependence of concentration of 146S particles and the number of RNA molecules is obtained in the form of a positive linear model. On the basis of the received linear model values of concentration 146S of foot-and-mouth disease virus particles in samples of raw materials are calculated.;EFFECT: invention enables fast and high-reliability determination of 146S concentration of foot-and-mouth disease virus particles in non-inactivated raw material for vaccine production.;4 cl, 4 tbl, 5 dwg, 6 ex
机译:技术领域本发明涉及生物技术,尤其涉及动物疫苗的生产,并且可以用于确定疫苗生产的非灭活原料中146S口蹄疫病毒颗粒的浓度。通过评估病毒体免疫捕获后回收的病毒RNA分子的数量可以确保这一点。从免疫复合物“ 146S颗粒-抗体”中分离RNA。 RNA提取物的纯度通过光谱分析和凝胶电泳进行评估。制备口蹄疫RNA病毒阳性标准品的一系列稀释液,该稀释液的分子数量对应于146S颗粒浓度从0.1到4.0 mcg / ml,稀释间隔为0.1 mcg / ml。从吸收光谱计算RNA分子的数目。以正线性模型的形式获得146S颗粒浓度和RNA分子数目的依赖性。基于所接收的原料样品中口蹄疫病毒颗粒的浓度146S的线性模型值;效果:本发明使得能够快速且高可靠性地确定口蹄疫的146S浓度用于生产疫苗的非灭活原料中的病毒颗粒。; 4 cl,4 tbl,5 dwg,6 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号